Cybin (CYBN) Earnings Date & Reports

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CYBN is expected to report earnings to rise 68.71% to -2 cents per share on November 13

Q3'24

Est.

$-0.02

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.03

Q4'23

Missed

by $0.03

Q3'23

Est.

$-0.03

The last earnings report on August 08 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 106.69K shares outstanding, the current market capitalization sits at 147.70M.

View a ticker or compare two or three

Compare

CYBN